BofA lowered the firm’s price target on Celanese to $124 from $132 and keeps a Neutral rating on the shares with recovery expectations “pared back again.” Celanese’s updated 2023 opens the possibility of EPS trailing the $9 low-end of the expected range, while the firm sees limited benefits from price/cost in Q4 and 2024 so far, the analyst tells investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CE: